Literature DB >> 7993658

Studies on human porin. XII. Eight monoclonal mouse anti-"porin 31HL" antibodies discriminate type 1 and type 2 mammalian porin channels/VDACs in western blotting and enzyme-linked immunosorbent assays.

H Winkelbach1, G Walter, C Morys-Wortmann, G Paetzold, D Hesse, B Zimmermann, H Flörke, S Reymann, U Stadtmüller, F P Thinnes.   

Abstract

Eight mouse monoclonal antibodies directed against the acetylated N-terminal part of the type 1 human VDAC Porin 31HL clearly discriminate type 1 and type 2 mammalian porin channels. This is shown by comparing synthetic N-terminal peptides of either channel type in Western dot blots or by ELISA. The data support the specificity of the anti-Porin 31HL antibodies and thus give further support to our recent observations on extramitochondrial expression of VDAC. In the plasmalemma of different mammalian cells VDAC forms part of an ubiquitous chloride channel complex, which in patch clamp measurements may figure as the outwardly rectifying depolarization-induced chloride channel that is affected in cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7993658     DOI: 10.1006/bmmb.1994.1042

Source DB:  PubMed          Journal:  Biochem Med Metab Biol        ISSN: 0885-4505


  10 in total

1.  p62/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both.

Authors:  Derek Narendra; Lesley A Kane; David N Hauser; Ian M Fearnley; Richard J Youle
Journal:  Autophagy       Date:  2010-11       Impact factor: 16.016

2.  Proteins of cytosol and amniotic fluid increase the voltage dependence of human type-1 porin.

Authors:  M Heiden; K Kroll; F P Thinnes; N Hilschmann
Journal:  J Bioenerg Biomembr       Date:  1996-04       Impact factor: 2.945

3.  Porin-type 1 proteins in sarcoplasmic reticulum and plasmalemma of striated muscle fibres.

Authors:  P R Junankar; A F Dulhunty; S M Curtis; S M Pace; F P Thinnes
Journal:  J Muscle Res Cell Motil       Date:  1995-12       Impact factor: 2.698

4.  Intracellular localization and isoform expression of the voltage-dependent anion channel (VDAC) in normal and dystrophic skeletal muscle.

Authors:  R Massa; L N Marliera; A Martorana; S Cicconi; D Pierucci; P Giacomini; V De Pinto; L Castellani
Journal:  J Muscle Res Cell Motil       Date:  2000       Impact factor: 2.698

5.  The expression level of the voltage-dependent anion channel controls life and death of the cell.

Authors:  Salah Abu-Hamad; Sara Sivan; Varda Shoshan-Barmatz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

6.  Human mitochondrial transmembrane metabolite carriers: tissue distribution and its implication for mitochondrial disorders.

Authors:  M Huizing; W Ruitenbeek; L P van den Heuvel; V Dolce; V Iacobazzi; J A Smeitink; F Palmieri; J M Trijbels
Journal:  J Bioenerg Biomembr       Date:  1998-06       Impact factor: 2.945

Review 7.  Importance of mitochondrial transmembrane processes in human mitochondriopathies.

Authors:  M Huizing; V DePinto; W Ruitenbeek; F J Trijbels; L P van den Heuvel; U Wendel
Journal:  J Bioenerg Biomembr       Date:  1996-04       Impact factor: 2.945

8.  Absence of mitochondrial superoxide dismutase results in a murine hemolytic anemia responsive to therapy with a catalytic antioxidant.

Authors:  J S Friedman; V I Rebel; R Derby; K Bell; T T Huang; F A Kuypers; C J Epstein; S J Burakoff
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

9.  Spatiotemporal regulation of ATP and Ca2+ dynamics in vertebrate rod and cone ribbon synapses.

Authors:  Jerry E Johnson; Guy A Perkins; Anand Giddabasappa; Shawntay Chaney; Weimin Xiao; Andrew D White; Joshua M Brown; Jenna Waggoner; Mark H Ellisman; Donald A Fox
Journal:  Mol Vis       Date:  2007-06-15       Impact factor: 2.367

Review 10.  Extramitochondrial porin: facts and hypotheses.

Authors:  G Báthori; I Parolini; I Szabó; F Tombola; A Messina; M Oliva; M Sargiacomo; V De Pinto; M Zoratti
Journal:  J Bioenerg Biomembr       Date:  2000-02       Impact factor: 2.945

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.